De Novo Synthesis of Tamiflu via a Catalytic Asymmetric Ring-Opening of meso-Aziridines with TMSN₃

Citations Over TimeTop 1% of 2006 papers

Abstract

An asymmetric ring-opening reaction of meso-aziridines with TMSN3 was developed using a catalyst prepared from Y(OiPr)3 and chiral ligand 2 in a 1:2 ratio. Excellent enantioselectivity was realized from a wide range of substrates with a practical catalyst loading. The products were efficiently converted to enantiomerically enriched 1,2-diamines, which are versatile chiral building blocks for pharmaceuticals and chiral ligands. This reaction was applied to a catalytic asymmetric synthesis of Tamiflu, a very important anti-influenza drug containing a chiral 1,2-diamino functionality.

Related Papers

• → Enantioselective Hydrogenation of Diarylmethanimines for Synthesis of Chiral Diarylmethylamines(2016)41 cited
• → Isosterically designed chiral catalysts: Rationale, optimization and their application in enantioselective nucleophilic addition to aldehydes(2020)10 cited
• → Ligand-modulated ring-expansion(2019)2 cited
• Synthesis of a Novel Chiral Ligand and Catalysis of the Ligand-OsO_4(2006)
• Synthesis of a Recyclable Chiral Ligand and Its Catalytic Performance for Asymmetric Dihydroxylation of Olefins(2005)